These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The fine-tuning of anti-oxidized low-density lipoprotein antibodies in cardiovascular disease and thrombosis. Freire de Carvalho J, Sherer Y, Shoenfeld Y. Thromb Haemost; 2007 Dec 20; 98(6):1157-9. PubMed ID: 18064307 [Abstract] [Full Text] [Related]
11. Oxidized LDL and anti-oxLDL antibody levels in peripheral atherosclerotic disease. Andican G, Seven A, Uncu M, Cantaşdemir M, Numan F, Burçak G. Scand J Clin Lab Invest; 2008 Dec 20; 68(6):473-8. PubMed ID: 18609113 [Abstract] [Full Text] [Related]
12. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Binder CJ, Hörkkö S, Dewan A, Chang MK, Kieu EP, Goodyear CS, Shaw PX, Palinski W, Witztum JL, Silverman GJ. Nat Med; 2003 Jun 20; 9(6):736-43. PubMed ID: 12740573 [Abstract] [Full Text] [Related]
13. Oxidation-specific epitopes are important targets of innate immunity. Chou MY, Hartvigsen K, Hansen LF, Fogelstrand L, Shaw PX, Boullier A, Binder CJ, Witztum JL. J Intern Med; 2008 May 20; 263(5):479-88. PubMed ID: 18410591 [Abstract] [Full Text] [Related]
14. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies. Napoli C. G Ital Cardiol; 1997 Dec 20; 27(12):1302-14. PubMed ID: 9470066 [Abstract] [Full Text] [Related]
16. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis. Ishigaki Y, Katagiri H, Gao J, Yamada T, Imai J, Uno K, Hasegawa Y, Kaneko K, Ogihara T, Ishihara H, Sato Y, Takikawa K, Nishimichi N, Matsuda H, Sawamura T, Oka Y. Circulation; 2008 Jul 01; 118(1):75-83. PubMed ID: 18559699 [Abstract] [Full Text] [Related]
17. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages. Kobayashi K, Tada K, Itabe H, Ueno T, Liu PH, Tsutsumi A, Kuwana M, Yasuda T, Shoenfeld Y, de Groot PG, Matsuura E. Lupus; 2007 Jul 01; 16(12):929-38. PubMed ID: 18042586 [Abstract] [Full Text] [Related]
19. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis. van Puijvelde GH, Hauer AD, de Vos P, van den Heuvel R, van Herwijnen MJ, van der Zee R, van Eden W, van Berkel TJ, Kuiper J. Circulation; 2006 Oct 31; 114(18):1968-76. PubMed ID: 17060383 [Abstract] [Full Text] [Related]
20. Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis. Peters MJ, van Halm VP, Nurmohamed MT, Damoiseaux J, Tervaert JW, Twisk JW, Dijkmans BA, Voskuyl AE. J Rheumatol; 2008 Aug 31; 35(8):1495-9. PubMed ID: 18597411 [Abstract] [Full Text] [Related] Page: [Next] [New Search]